Abstract:As the Nobel laureate Luigi Pirandello wrote in his novels, identities can be evanescent. Although a quarter of a century has passed since regulatory T cells (Treg) were first described, new studies continue to reveal surprising and contradictory features of this lymphocyte subset. Treg cells are the core of the immunological workforce engaged in the restraint of autoimmune or inflammatory reactions, and their characterization has revealed substantial heterogeneity and complexity in the phenotype and gene expression profiles, proving them to be a most versatile and adaptive cell type, as exemplified by their plasticity in fine-tuning immune responses. Defects in Treg function are associated with several autoimmune diseases, including multiple sclerosis, which is caused by an inappropriate immune reaction toward brain components; conversely, the beneficial effects of immunomodulating therapies on disease progression have been shown to partly act upon the biology of these cells. Both in animals and in humans the pool of circulating Treg cells is a mixture of natural (nTregs) and peripherally-induced Treg (pTregs). Particularly in humans, circulating Treg cells can be phenotypically subdivided into different subpopulations, which so far are not well-characterized, particularly in the context of autoimmunity. Recently, Treg cells have been rediscovered as mediators of tissue healing, and have also shown to be involved in organ homeostasis. Moreover, stability of the Treg lineage has recently been addressed by several conflicting reports, and immune-suppressive abilities of these cells have been shown to be dynamically regulated, particularly in inflammatory conditions, adding further levels of complexity to the study of this cell subset. Finally, Treg cells exert their suppressive function through different mechanisms, some of which—such as their ectoenzymatic activity—are particularly relevant in CNS autoimmunity. Here, we will review the phenotypically and functionally discernible Treg cell subpopulations in health and in multiple sclerosis, touching also upon the effects on this cell type of immunomodulatory drugs used for the treatment of this disease.

The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases

The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases

Regulatory T cells: Development, function and role in autoimmunity

Regulatory T Cells: Regulation of Identity and Function

Regulatory T Cells: the Many Faces of Foxp3

An autoimmune transcriptional circuit drives FOXP3 + regulatory T cell dysfunction

Generation and Regulation of CD8(+) Regulatory T Cells.

Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases

Research Progress on Regulatory T Cells and Their Relationship with Autoimmune Diseases

The regulation of immune tolerance by FOXP3

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity

Inhibition of follicular T-helper cells by CD8 + regulatory T cells is essential for self tolerance

Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

The Molecular Mechanisms of Regulatory T Cell Immunosuppression

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells

Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs

TREG-cell therapies for autoimmune rheumatic diseases

Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function